| 摘要 |
The present invention relates to a pharmaceutical composition for preventing or treating peritoneal fibrosis, comprising taurine-conjugated ursodeoxycholic acid (TUDCA) or a pharmaceutically acceptable salt thereof as an active ingredient, and to a peritoneal dialysis solution. The TUDCA or the pharmaceutically acceptable salt thereof of the present invention effectively inhibits the apoptosis of EMT and peritoneal cells, and can be efficiently used for preventing or treating peritoneal fiberization or peritoneal fibrosis. |
